In short
BI-RADS is a number, not a diagnosis. 0 means the reading is unfinished, 1 and 2 are normal, 3 has a ceiling of 2 percent, 4 splits into three very different bands, and 5 is 95 percent or more.
Emergency if: Go to emergency care for a breast that turns red, swollen, hot and painful over hours or days, especially with fever, shivering or feeling generally unwell. That picture can be a spreading infection or abscess needing urgent treatment, and the same appearance can be an inflammatory breast cancer that is missed when it is assumed to be a simple infection and left for weeks.
On this page
01
What BI-RADS is, and why the result is a number
BI-RADS is the Breast Imaging Reporting and Data System, published by the American College of Radiology. The ACR describes it as providing standardised breast imaging terminology, report organisation, assessment structure and a classification system for mammography, ultrasound and MRI of the breast. The end of the report is a single final assessment category from 0 to 6. Each category carries a recommended action, and for several of them an agreed likelihood that the finding is cancer. It is a communication standard, not a stage and not a diagnosis.
The current version is the BI-RADS v2025 manual, which the ACR describes as an extension of the fifth edition of the BI-RADS Atlas and the first move to year-based versioning. Contrast-enhanced mammography has become an intrinsic section rather than a supplement, breast composition descriptors were updated, elasticity descriptors were added for ultrasound and implant descriptors for MRI, and an optional subdivision of category 4 into 4A, 4B and 4C was added for breast MRI so that it can mirror the other modalities. The assessment categories and their probability bands carried over.
Because those bands are fixed, a category is really a probability statement written as a number, which is why two people with the same word on their report can face very different conversations. This story is about reading that number. Our breast cancer guide covers the disease, its treatment and what a diagnosis involves, and our guide to cancer screening tests covers who is offered screening and how often.
02
BI-RADS 0: does incomplete mean they found something?
Not necessarily, and often not. Category 0 means incomplete: in the American Cancer Society's wording, additional imaging evaluation and, or, comparison to prior mammograms or other imaging tests is needed. Two quite different situations produce it. Either something on the picture needs better views before it can be judged, or the reader simply has nothing to compare against. A first mammogram, or a first one at a new centre, produces category 0 more often for that second reason alone.
What happens next is more imaging on the same day or soon after: extra mammogram views, spot compression or magnification, often a targeted ultrasound, and then a final category is assigned. The practical thing you can do is bring or send your earlier films and reports if they were taken elsewhere. Comparison is not a formality; it is one of the two named routes out of category 0, and a finding that has looked identical for years is a very different object from a new one.
The v2025 manual makes those two situations explicit, separating the need for further imaging from the need for earlier examinations to judge whether a finding is stable, so a recall letter still means what it has always meant. It is worth saying plainly, because the letter itself rarely does: a recall is an unfinished reading, not a result. Ask when the extra imaging is booked and whether the earlier films have been retrieved, rather than trying to read anything into the word incomplete.
03
1 and 2: what is a benign finding they still wrote down?
Category 1 is negative: nothing new or abnormal was found. Category 2 is a benign, non-cancerous finding, which the American Cancer Society describes as meaning there is no sign of cancer, but the radiologist chooses to describe a finding. In the BI-RADS scheme both categories sit at essentially zero percent likelihood of malignancy. As far as what happens next is concerned they are the same result: return to whatever routine screening interval your programme uses.
The reason a benign finding is written down at all is the comparison problem from the previous section. A clearly benign feature that is named and described this year becomes the baseline for the next reader, and a finding known to have been present and unchanged is the single most useful thing a future radiologist can have. In other words, a category 2 report is doing work for you several years ahead, which is why it is not left blank.
The common misreading is to treat category 2 as a milder version of something suspicious and to go looking for extra tests or a second opinion. It is not on that ladder at all. If the word benign is what you were given and no follow-up interval was named, that is the answer, and the next thing on your calendar is your usual screening appointment rather than anything in between. There is one exception, and it matters more than the rule: the report is a reading of a picture, not an examination of you. A lump you can feel, a newly inturned nipple, skin that dimples like orange peel or blood-stained discharge from one nipple still needs a clinician to examine you, whatever number the mammogram carried.
04
BI-RADS 3: why six months of waiting instead of a biopsy?
Because the category is defined by a ceiling. Probably benign means a likelihood of malignancy greater than zero but no more than 2 percent — the American Cancer Society puts it as a very low, no more than 2 percent, chance of being cancer. At that ceiling, at most about one finding in fifty in the whole category is a cancer. Biopsying all of them would mean a great many procedures, each with its own bruising, anxiety and scar tissue, to find that one.
So the alternative is to watch instead. BI-RADS pairs category 3 with short-interval follow-up, conventionally at six months, and the American Cancer Society describes repeat imaging in 6 to 12 months and regularly after that until the area has not changed for a while, usually at least two years. Stability across that period is itself the evidence: a finding that has not moved over two years of imaging is behaving in the way benign findings behave.
The safety of this plan depends entirely on your attending the follow-ups, and that is the part worth saying out loud in the room. If travel, cost or timing makes a two-year sequence of appointments unrealistic for you, say so, because a biopsy now may be the better plan for you even though the category does not demand one. And if the area changes, grows or becomes palpable before the next date, that is a reason to come in early rather than wait for the appointment.
05
4A, 4B, 4C and 5 — what are the actual odds?
Category 4 means a suspicious abnormality for which biopsy should be considered, and it is deliberately split, because the word suspicious spans an enormous range. The bands are 4A, low likelihood of being cancer, more than 2 percent but no more than 10 percent; 4B, moderate likelihood, more than 10 percent but no more than 50 percent; and 4C, high likelihood, more than 50 percent but less than 95 percent. Category 5 is highly suggestive of malignancy, at a high chance of at least 95 percent.
Read across those numbers and the difference is stark. A 4A finding is one where the most likely single outcome, by a wide margin, is a benign biopsy result — at least nine in ten are not cancer — but the chance is high enough that looking is the right call. A 4C finding is the reverse, and people are often told that a plan is being prepared in parallel. A category 5 report means the imaging is already close to conclusive, and the biopsy exists to confirm it and to type the tumour for treatment.
Category 6 is not a suspicion at all. It means known biopsy-proven malignancy, and it is used for imaging done after a cancer has already been diagnosed — for instance to follow how a tumour is responding before surgery. The v2025 manual changed its stated management from surgical excision when appropriate to clinical follow-up and definitive local therapy, which is usually but not only surgical, recognising that treatment does not always start with an operation.
06
What breast density A to D means for me
Density describes how much fibrous and glandular tissue your breasts contain compared with fat, and the four categories are a, almost entirely fatty; b, scattered fibroglandular density; c, heterogeneously dense, which may obscure small masses; and d, extremely dense, which lowers mammographic sensitivity. The National Cancer Institute gives the approximate distribution as about 10 percent in the first group, 40 percent in the second, 40 percent in the third and 10 percent in the fourth, and notes that nearly half of women aged 40 and over who have mammograms are found to have dense breast tissue.
Density does two separate things, and confusing them causes unnecessary alarm. First, it makes the picture harder to read: dense tissue is white on a mammogram and so are many cancers, so a normal result promises a little less in category c or d than it does in category a. Second, and independently of that, women with dense breasts have a higher risk of breast cancer than women with fatty breasts, although the reason is not understood.
The reporting rules differ by country, which is why some reports mention density and others do not. In the United States, since 10 September 2024, all patient mammogram reports must describe breast density as either not dense or dense. Density itself is a normal variation, not an abnormality and not a finding, and it is not something you did or can change. Treat it as context for what the report can and cannot promise.
07
Do I need an ultrasound or MRI as well?
For dense breasts alone, the honest answer is that it is not settled, and anyone who tells you otherwise is ahead of the evidence. The National Cancer Institute states that there is not yet enough evidence to recommend for or against additional imaging tests such as ultrasound or MRI to screen for breast cancer in women with dense breasts, citing the US Preventive Services Task Force. The American Cancer Society describes the same lack of consensus: 3D mammography, ultrasound and MRI find some cancers missed on a standard mammogram, at the price of higher cost and more false-positive findings.
A targeted ultrasound after a recall or for a lump you can feel is a different question and not the same debate. That is diagnostic imaging aimed at one area, and BI-RADS covers ultrasound and MRI with the same assessment categories, which is why a report from a targeted scan also ends in a number from 0 to 6. If you are offered one in that setting, it is not supplemental screening and the uncertainty described above does not apply to it.
If you have been told you are at high risk for a reason other than density — a strong family history, a known inherited gene change, or radiotherapy to the chest when you were young — supplemental imaging becomes a separate conversation, decided on that risk and usually by a specialist service. The letter on your density line is not what drives it, and a density category on its own is not a referral criterion.
08
What to ask before agreeing to a biopsy
Ask for the category and the sub-category, in that order. Suspicious covers everything from just over 2 percent to just under 95 percent, and 4A and 4C are the same word attached to opposite expectations. Knowing which band you are in changes nothing about whether the biopsy is worth doing, but it changes what you should brace for and what you should tell the people waiting at home, which is most of what the days before a result are made of.
Ask whether your earlier images were obtained and compared, since comparison is one of the two routes out of an incomplete reading and can settle a finding without any procedure. Ask which scan found it and whether the biopsy will be guided by that same modality, because a finding visible only on one type of imaging has to be sampled under that type. And ask whether this is a needle biopsy in the imaging department or something larger, so that you know what you are consenting to.
Finally, ask what a benign result would mean in practice: whether it closes the episode or brings a short-interval follow-up, which is a common and reasonable outcome and not a sign that anyone doubts the result. The v2025 manual updates its auditing and outcomes-monitoring section, so a unit can in principle tell you its own recall and cancer detection figures. A service willing to discuss its numbers is a good sign in itself.
Breast symptoms that should not wait for the next mammogram
Routine — see a doctor
A recall letter for extra views, a category 3 with a six-month follow-up date, or a report that simply notes dense breast tissue: these are routine appointments. Make them, keep the whole sequence of follow-up dates, and bring any earlier films from another centre.
Same-day — call promptly
Have a doctor examine you within a day or two for a new lump or thickened area that does not come and go with your cycle, skin dimpling that looks like orange peel, swelling of part of a breast, a nipple that has newly turned inward, or blood-stained discharge from one nipple. A normal mammogram does not overrule a lump you can feel, and any new breast mass needs checking by a clinician.
Emergency — act now
Go to emergency care for a breast that turns red, swollen, hot and painful over hours or days, especially with fever, shivering or feeling generally unwell. That picture can be a spreading infection or abscess needing urgent treatment, and the same appearance can be an inflammatory breast cancer that is missed when it is assumed to be a simple infection and left for weeks.
Sources
- American Cancer Society — understanding your mammogram reportcancer.org
- American Cancer Society — dense breast tissue and your mammogram reportcancer.org
- How does ACR BI-RADS v2025 change the radiologist's approach? A practical guidepmc.ncbi.nlm.nih.gov
- American College of Radiology — BI-RADSacr.org
- National Cancer Institute — dense breasts: answers to commonly asked questionscancer.gov
- American Cancer Society — breast cancer signs and symptomscancer.org
Share this story
Curious where your own values stand?
Two minutes from upload to a full visual picture. Free to analyze.